Consumer demand for new and innovative drug, over-the-counter, and regulated consumer products is helping to fuel the growth of the excipient market. According to American Pharmaceutical Review‘s article, the excipients market could reach $9.9 B by 2021:
Building on Strength: Excipient Supply Chain Prepares to Meet Global Demand
Posted: December 22, 2017
American Pharmaceutical Review
By Nigel Walker
The excipient market is enjoying a growth period. According to market and trend analysis firm Grand View Research, demand for stabilizers anti-adherents, bulk fillers/diluents, lubricants, disintegrants, binders, coatings, polymers and other performance-enhancing ingredients is projected at 744,621 tons by 2020. Every category of excipients is predicted to rise steadily over the foreseeable future, and at a healthy, sustained, compound annual growth rate (CAGR). The ongoing rise in the demand for safe, affordable, and effective medications is affecting all sectors of the industry. This is not limited to excipient suppliers, who are refining their strategies to retain and grow market share.
Research & Markets projects the overall market for excipients will reach $7.7 billion by 2022, with a CAGR of 7.3%.2 On the low end of recent estimates is reports firm IndustryARC’s projected $5.4 billion total market value, stemming from a 6.2% CAGR. Even more optimistic, research firm Mordor Intelligence, anticipates the global pharmaceutical excipients market will reach $9.9 billion by the end of 2021, sustained by a 7.2% CAGR that began in 2016. Regadless of how large the market eventually turns out to be, it will likely be substantial and capable of sustaining this growth, indicative of the industry overall